Cancer patients receiving immune checkpoint inhibitor (ICI) therapy may experience more severe toxicity and have a greater risk of death if they have recently used proton pump inhibitors (PPIs), ...

A quality improvement project incorporated 4 interventions to improve the rate of CLABSIs in pediatric hematology/oncology/bone marrow transplantation patients.

Finding seen for patients with chronic lymphocytic leukemia receiving immunoglobulin replacement therapy regularly.

CRS is a life-threatening condition that results in the excessive release of cytokines into the bloodstream, causing inflammation and damage to organs and tissues.

Adjuvant chemoradiation combined with camrelizumab was well tolerated and yielded significantly improved long-term survival,” the researchers wrote.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

Investigators examined the epidemiology of acral lentiginous melanoma in Black and White patients to establish if delayed diagnosis contributes to outcome disparities.

Postmastectomy radiotherapy appeared to increase the risks for minor complications and reoperations after immediate breast reconstruction.

Despite the benefits of palliative care, less than 10% of referrals for 157 patients with hematologic cancers were to palliative care specialists.

Researchers sought to determine whether it would be feasible to administer treatment with HD-MTX for pediatric patients with advanced MB-NHL in Malawi.

Most deprived and/or non-Hispanic Black-concentrated areas had significantly higher advanced-to-localized IRRs for breast, cervical cancer.

Prostate cancer-specific mortality rates 2.4 and 4.7 percent for unfavorable intermediate-risk and high-risk GG1.